---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-143469"
form_type: "8-K/A"
ticker: "CALC"
cik: "0001534133"
company_name: "CalciMedica, Inc."
filed_at: "2023-05-12T23:59:59+00:00"
generated_at: "2026-06-15T02:28:59.385203+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# CalciMedica restates FY2022 results; net loss cut $6.7M on valuation errors

## Summary
- Board concluded on May 8, 2023 that FY2022 financials contained errors in convertible note and warrant liability valuations.
- Restatement reduced net loss and comprehensive loss from $14.5M to $7.8M; EPS improved from ($5.08) to ($3.20).
- Warrant liability restated to $2.6M (from $4.2M); convertible promissory notes restated to $5.2M (from $8.9M).
- Prior FY2022 financials and related communications should no longer be relied upon.

## SEC filing metadata
- accession: 0001193125-23-143469
- form_type: 8-K/A
- ticker: CALC
- cik: 0001534133
- company_name: CalciMedica, Inc.
- filed_at: 2023-05-12T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534133/000119312523143469/0001193125-23-143469-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534133/000119312523143469/d386273d8ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-143469
- JSON: https://secwatch.observer/filing/0001193125-23-143469.json
- Plain text: https://secwatch.observer/filing/0001193125-23-143469.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.